VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2016

Jul 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2016-07-06

Reporting Person: BOGER JOSHUA S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-06	Common Stock	M	5140	$35.35	Acquired	273365	Direct
2016-07-06	Common Stock	S	100	$86.47	Disposed	273265	Direct
2016-07-06	Common Stock	S	600	$87.99	Disposed	272665	Direct
2016-07-06	Common Stock	S	4300	$89.17	Disposed	268365	Direct
2016-07-06	Common Stock	S	140	$89.69	Disposed	268225	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-06	Stock Option (Right to Buy)	$35.35	M	5140	Disposed	2016-07-19	Common Stock (5140)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13286	Indirect
Common Stock	122700	Indirect

Footnotes

F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3: Open market sales reported on this line occurred at a weighted average price of $87.99 (range $87.53 to $88.24).

F4: Open market sales reported on this line occurred at a weighted average price of $89.17 (range $88.64 to $89.56).

F5: Fully vested.